AGP Picks
View all

DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on July 24, 2026

National Black Church Initiative Urges the Senate to Pass the Clarity Act Before the August Recess
Microchip Technology Signs Definitive Agreement to Acquire Hailo
MAJC Goes Live Nationwide, Giving Every Restaurant Worker a Free Digital Teammate
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists
Purple named finalist in the Lloyds British Business Excellence Awards 2026
Self Inspection Raises $10 Million to Build the System of Record for Vehicle Condition
Physician Reviewer Networks: How Leading Health Plans Are Solving the Challenge Without Sacrificing Quality
Fly.io Doubles Down on Computers for Agents with $25M to Deliver the Next Generation of AI Infrastructure
HoneyPezil Publishes Updated 2026 Product Information for Its Brain Health and Memory Support Capsules
San Jose Science Center Scales Hands-On Engineering Education Across Kenya
Finland's 2027 Licensing Reform: Policy Implications for Europe by Pikakasinot
Quantum X Labs Reports Meaningful Error Correction Decoder Results with NVIDIA CUDA-Q QEC
Subcutaneous PD-1 Inhibitors Transition from Novelty to Routine Care as Oncologists Tailor Use by Tumor Type, According to Spherix Global Insights
Hormuz diversions plateau at 4x baseline as Navi Mumbai dwell rises to 21 days
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

DC STEM Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.